AI-driven drug firm METiS mulls Hong Kong IPO

China’s artificial intelligence-driven drug firm METiS Pharmaceuticals is said to be considering listing in Hong Kong to raise up to US$200 million (HK$1.56 billion), Bloomberg News reported.

The Shenzhen-based company is working with advisers to arrange an initial public offering, possibly before the end of this year, according to Bloomberg’s report.

Discussions are still ongoing, and details such as the size and timing of the IPO are subject to change, according to sources.

STAFF REPORTER